Literature DB >> 2616615

[The biotransformation of leiocarposide and salicin phenol glycosides--examples for special consideration of the absorption and metabolism of glycosidic compounds].

G Fötsch1, S Pfeifer.   

Abstract

After parenteral administration of leiocarposide (1, 3-beta-D-glucopyranosyloxy-2-methoxy-6-hydroxybenzoic acid-2'-beta-D-glucopyranosyloxybenzylester) and salicin to the rat the glycosides were mostly excreted unchanged in urine. In contrast to the oral administration (see [1]) only small amounts of metabolites [1: 0.2% of the dose as leiocarpic acid and 0.1% salicylic acid; 2: 0.05% 5] were observed. By in vitro experiments could be shown, that the hydrolysis of ester and glycosidic bonds from 1 to 3 and saligenin and from 2 to 4 took place microbially mostly in the cecum and colon of the rats. The reactions are also visible in the homogenate of kidney. Präparations of liver, lung and serum showed no activity. 4 in the homogenates of liver, kidney and lung, in the gut-wall and the serum was oxidized to 5. The further product of oxidation of 5, gentisic acid, arise only in liver homogenate.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2616615

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  3 in total

1.  Does excretion of secondary metabolites always involve a measurable metabolic cost? Fate of plant antifeedant salicin in common brushtail possum, Trichosurus vulpecula.

Authors:  S McLean; G J Pass; W J Foley; S Brandon; N W Davies
Journal:  J Chem Ecol       Date:  2001-06       Impact factor: 2.626

2.  A Combined LC-MS Metabolomics- and 16S rRNA Sequencing Platform to Assess Interactions between Herbal Medicinal Products and Human Gut Bacteria in Vitro: a Pilot Study on Willow Bark Extract.

Authors:  Eva-Maria Pferschy-Wenzig; Kaisa Koskinen; Christine Moissl-Eichinger; Rudolf Bauer
Journal:  Front Pharmacol       Date:  2017-12-13       Impact factor: 5.810

3.  Identification of Salicylates in Willow Bark (Salix Cortex) for Targeting Peripheral Inflammation.

Authors:  Kyriaki Antoniadou; Corinna Herz; Nguyen Phan Khoi Le; Verena Karolin Mittermeier-Kleßinger; Nadja Förster; Matthias Zander; Christian Ulrichs; Inga Mewis; Thomas Hofmann; Corinna Dawid; Evelyn Lamy
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.